On the public citation graph
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
0 signed · 516 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s10096-009-0833-2openalex-snapshot
Fosfomycin: an old, new friend?
inferredcites →https://doi.org/10.1016/j.diagmicrobio.2010.02.001openalex-snapshot
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
inferredcites →https://doi.org/10.1016/j.diagmicrobio.2012.07.010openalex-snapshot
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
inferredcites →https://doi.org/10.1016/j.diagmicrobio.2012.08.025openalex-snapshot
Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin
inferredcites →https://doi.org/10.1016/j.ijantimicag.2009.08.013openalex-snapshot
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
inferredcites →https://doi.org/10.1016/j.ijantimicag.2009.10.005openalex-snapshot
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
inferredcites →https://doi.org/10.1016/j.ijantimicag.2010.09.002openalex-snapshot
Adverse events associated with intravenous fosfomycin
inferredcites →https://doi.org/10.1016/j.ijantimicag.2011.01.012openalex-snapshot
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
inferredcites →https://doi.org/10.1016/j.ijantimicag.2011.09.012openalex-snapshot
In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1016/j.ijantimicag.2013.02.015openalex-snapshot
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1016/j.ijid.2009.01.006openalex-snapshot
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult
inferredcites →https://doi.org/10.1016/j.ijid.2009.09.001openalex-snapshot
Evaluation of susceptibility testing methods for polymyxin
inferredcites →https://doi.org/10.1016/j.ijid.2014.05.012openalex-snapshot
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
inferredcites →https://doi.org/10.1016/j.jinf.2013.04.017openalex-snapshot
Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil
inferredcites →https://doi.org/10.1016/j.molmed.2012.03.003openalex-snapshot
Carbapenem resistance in Enterobacteriaceae: here is the storm!
inferredcites →https://doi.org/10.1016/s1473-3099(09)70325-1openalex-snapshot
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
inferredcites →https://doi.org/10.1086/497831openalex-snapshot
Dissemination of the Metallo- -Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia
inferredcites →https://doi.org/10.1086/512370openalex-snapshot
Detection and Spread of Escherichia coli Possessing the Plasmid-Borne Carbapenemase KPC-2 in Brooklyn, New York
inferredcites →https://doi.org/10.1086/526775openalex-snapshot
Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline
inferredcites →https://doi.org/10.1086/527442openalex-snapshot
Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
inferredcites →https://doi.org/10.1086/649865openalex-snapshot
An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
inferredcites →https://doi.org/10.1089/mdr.2009.0031openalex-snapshot
Antimicrobial Susceptibility Patterns of KPC-Producing or CTX-M-Producing Enterobacteriaceae
inferredcites →https://doi.org/10.1093/cid/cir137openalex-snapshot
Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case Report
inferredcites →https://doi.org/10.1093/cid/cir611openalex-snapshot
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
inferredcites →https://doi.org/10.1093/cid/cis588openalex-snapshot
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
inferredcites →https://doi.org/10.1093/cid/cis909openalex-snapshot
Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
inferredcites →https://doi.org/10.1093/cid/cis969openalex-snapshot
Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
inferredcites →https://doi.org/10.1093/cid/cit334openalex-snapshot
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
inferredcites →https://doi.org/10.1093/cid/cit453openalex-snapshot
Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
inferredcites →https://doi.org/10.1093/jac/dki175openalex-snapshot
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents
inferredcites →https://doi.org/10.1093/jac/dkl441openalex-snapshot
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
inferredcites →https://doi.org/10.1093/jac/dkl562openalex-snapshot
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
inferredcites →https://doi.org/10.1093/jac/dkp139openalex-snapshot
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
inferredcites →https://doi.org/10.1093/jac/dkq108openalex-snapshot
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
inferredcites →https://doi.org/10.1093/jac/dkq226openalex-snapshot
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
inferredcites →https://doi.org/10.1093/jac/dkq285openalex-snapshot
The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic
inferredcites →https://doi.org/10.1093/jac/dkq408openalex-snapshot
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
inferredcites →https://doi.org/10.1093/jac/dkr239openalex-snapshot
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
inferredcites →https://doi.org/10.1093/jac/dkr299openalex-snapshot
Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media
inferredcites →https://doi.org/10.1093/jac/dks121openalex-snapshot
OXA-48-like carbapenemases: the phantom menace
inferredcites →https://doi.org/10.1093/jac/dks270openalex-snapshot
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases
inferredcites →https://doi.org/10.1093/jac/dks437openalex-snapshot
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
inferredcites →https://doi.org/10.1093/jac/dks523openalex-snapshot
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
inferredcites →https://doi.org/10.1093/jac/dku168openalex-snapshot
Combination therapy for carbapenem-resistant Gram-negative bacteria
inferredcites →https://doi.org/10.1111/1469-0691.12091openalex-snapshot
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
inferredcites →https://doi.org/10.1111/1469-0691.12697openalex-snapshot
Treating infections caused by carbapenemase-producing Enterobacteriaceae
inferredcites →https://doi.org/10.1111/j.1469-0691.2009.02921.xopenalex-snapshot
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
inferredcites →https://doi.org/10.1111/j.1469-0691.2011.03514.xopenalex-snapshot
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
inferredcites →https://doi.org/10.1111/j.1469-0691.2011.03553.xopenalex-snapshot
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
inferredcites →https://doi.org/10.1111/j.1469-0691.2012.03823.xopenalex-snapshot
Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria
inferredcites →https://doi.org/10.1111/nyas.12537openalex-snapshot
Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
inferredcites →https://doi.org/10.1128/aac.00026-10openalex-snapshot
In VivoEfficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- ProducingKlebsiella pneumoniae
inferredcites →https://doi.org/10.1128/aac.00188-13openalex-snapshot
Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1128/aac.00299-07openalex-snapshot
Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
inferredcites →https://doi.org/10.1128/aac.00387-11openalex-snapshot
Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
inferredcites →https://doi.org/10.1128/aac.00693-09openalex-snapshot
Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase
inferredcites →https://doi.org/10.1128/aac.00784-09openalex-snapshot
Regional Dissemination of KPC-Producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1128/aac.01020-10openalex-snapshot
Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan
inferredcites →https://doi.org/10.1128/aac.01114-09openalex-snapshot
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
inferredcites →https://doi.org/10.1128/aac.01222-13openalex-snapshot
Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
inferredcites →https://doi.org/10.1128/aac.01314-10openalex-snapshot
Optimization of Aminoglycoside Therapy
inferredcites →https://doi.org/10.1128/aac.01420-10openalex-snapshot
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1128/aac.01733-10openalex-snapshot
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
inferredcites →https://doi.org/10.1128/aac.01896-13openalex-snapshot
Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
inferredcites →https://doi.org/10.1128/aac.02166-13openalex-snapshot
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
inferredcites →https://doi.org/10.1128/aac.02399-12openalex-snapshot
Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
inferredcites →https://doi.org/10.1128/aac.02476-13openalex-snapshot
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
inferredcites →https://doi.org/10.1128/aac.02684-13openalex-snapshot
Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012)
inferredcites →https://doi.org/10.1128/aac.05080-11openalex-snapshot
Dose Adjustment of Polymyxins for Renal Insufficiency
inferredcites →https://doi.org/10.1128/aac.06268-11openalex-snapshot
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
inferredcites →https://doi.org/10.1128/aac.06364-11openalex-snapshot
The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1128/aac.48.11.4438-4440.2004openalex-snapshot
Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp
inferredcites →https://doi.org/10.1128/jcm.00404-09openalex-snapshot
Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis
inferredcites →https://doi.org/10.1128/jcm.02466-08openalex-snapshot
Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection
inferredcites →https://doi.org/10.1177/0091270003257225openalex-snapshot
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
inferredcites →https://doi.org/10.1177/0091270006291035openalex-snapshot
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
inferredcites →https://doi.org/10.1185/03007995.2012.748653openalex-snapshot
Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
inferredcites →https://doi.org/10.1186/1471-2253-13-13openalex-snapshot
KPC - 3 Klebsiella pneumoniaeST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients
inferredcites →https://doi.org/10.1186/1476-0711-11-32openalex-snapshot
Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
inferredcites →https://doi.org/10.1186/cc13858openalex-snapshot
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
inferredcites →https://doi.org/10.1517/14656566.2013.763030openalex-snapshot
Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases)
inferredcites →https://doi.org/10.15620/cdc:82532openalex-snapshot
Antibiotic resistance threats in the United States, 2019
inferredcites →https://doi.org/10.1586/14787210.2013.845523openalex-snapshot
Combination therapy for carbapenem-resistant Gram-negative bacteria
inferredcites →https://doi.org/10.1586/eri.12.138openalex-snapshot
Bloodstream infections caused by carbapenemase-producingKlebsiella pneumoniae: a clinical perspective
inferredcites →https://doi.org/10.1586/eri.12.162openalex-snapshot
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
inferredcites →https://doi.org/10.3201/eid1702.101313openalex-snapshot
New Delhi Metallo-β-Lactamase from Traveler Returning to Canada1
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.5281/zenodo.4382206openalex-extracted
Carbapenem Resistance in Klebsiella pneumoniae and Escherichia Coli at Dr. Muhammad Hoesin Central General Hospital, Palembang
inferred← citeshttps://doi.org/10.1002/cmdc.202100321openalex-snapshot
Pyrazole‐Thiazole Core‐Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem‐Resistant Enterobacteriaceae (CRE)
inferred← citeshttps://doi.org/10.1002/cpdd.1616openalex-snapshot
Plazomicin Pharmacokinetics in Indian Complicated Urinary Tract Infections Patients: A Subgroup Analysis from a Phase 2 Study
inferred← citeshttps://doi.org/10.1002/lt.24486openalex-snapshot
Multidrug‐resistant organisms in liver transplant: Mitigating risk and managing infections
inferred← citeshttps://doi.org/10.1002/phar.1984openalex-snapshot
IMP‐6 Carbapenemase‐Producing Enterobacteriaceae Bacteremia Successfully Treated with Amikacin‐Meropenem in Two Patients
inferred← citeshttps://doi.org/10.1002/phar.70118openalex-snapshot
Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
inferred← citeshttps://doi.org/10.1007/978-1-4939-7334-7_7openalex-snapshot
Resistance Mechanisms: A Problem and an Approach to the Solution
inferred← citeshttps://doi.org/10.1007/978-1-4939-7334-7_8openalex-snapshot
Interpretive Reading of the Antibiogram: A Tool for Clinical Practice
inferred← citeshttps://doi.org/10.1007/978-3-030-58975-2_17openalex-snapshot
Medicinal Plant-Derived Antimicrobials’ Fight Against Multidrug-Resistant Pathogens
inferred← citeshttps://doi.org/10.1007/978-3-031-84469-0_6openalex-snapshot
Microbiology and Infectious Agents
inferred← citeshttps://doi.org/10.1007/s00216-024-05209-9openalex-snapshot
Raman spectrum combined with deep learning for precise recognition of Carbapenem-resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1007/s00284-018-1475-3openalex-snapshot
Tracking Multidrug-Resistant Klebsiella pneumoniae from an Italian Hospital: Molecular Epidemiology and Surveillance by PFGE, RAPD and PCR-Based Resistance Genes Prevalence
inferred← citeshttps://doi.org/10.1007/s00430-016-0450-5openalex-snapshot
Effective immunosuppression with dexamethasone phosphate in the Galleria mellonella larva infection model resulting in enhanced virulence of Escherichia coli and Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1007/s10096-017-3114-5openalex-snapshot
Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections
inferred← citeshttps://doi.org/10.1007/s10096-023-04581-1openalex-snapshot
Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors
inferred← citeshttps://doi.org/10.1007/s11274-026-04884-3openalex-snapshot
Restoration of β-lactam activity by nacubactam combinations against extensively drug-resistant K. pneumoniae harbouring diverse carbapenem resistance gene
inferred← citeshttps://doi.org/10.1007/s11604-021-01094-9openalex-snapshot
Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19
inferred← citeshttps://doi.org/10.1007/s11739-017-1675-zopenalex-snapshot
Every cloud has a silver lining
inferred← citeshttps://doi.org/10.1007/s11908-015-0510-9openalex-snapshot
Carbapenem-Resistant Enterobacteriaceae Infections in Children
inferred← citeshttps://doi.org/10.1007/s12602-026-11046-2openalex-snapshot
Leuconostoc mesenteroides TH-ST373 Cell-Free Supernatant Against Multidrug-Resistant Escherichia coli
inferred← citeshttps://doi.org/10.1007/s13205-017-0848-9openalex-snapshot
Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens
inferred← citeshttps://doi.org/10.1007/s15010-023-02108-6openalex-snapshot
Ceftazidime–avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s40121-020-00286-6openalex-snapshot
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
inferred← citeshttps://doi.org/10.1007/s40121-021-00479-7openalex-snapshot
Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1007/s40121-022-00682-0openalex-snapshot
Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1007/s43450-023-00374-xopenalex-snapshot
Brazilian Brown Propolis: an Overview About Its Chemical Composition, Botanical Sources, Quality Control, and Pharmacological Properties
inferred← citeshttps://doi.org/10.1016/b978-0-12-820054-4.00010-0openalex-snapshot
Inhibition of Bacterial Growth and Removal of Antibiotic-Resistant Bacteria From Wastewater
inferred← citeshttps://doi.org/10.1016/j.ajic.2017.06.028openalex-snapshot
Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India
inferred← citeshttps://doi.org/10.1016/j.ajic.2019.03.020openalex-snapshot
Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116508openalex-snapshot
Functional characterisation and modification of a novel Kunitzin peptide for use as an anti-trypsin antimicrobial peptide against drug-resistant Escherichia coli
inferred← citeshttps://doi.org/10.1016/j.bjm.2017.01.008openalex-snapshot
Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates
inferred← citeshttps://doi.org/10.1016/j.bmc.2024.117604openalex-snapshot
Synergistic effect of tryptamine-urea derivatives to overcome the chromosomally-mediated colistin resistance in Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.130008openalex-snapshot
Extended structure-activity relationship studies of the [1,2,5]oxadiazolo[3,4-b]pyrazine-containing colistin adjuvants
inferred← citeshttps://doi.org/10.1016/j.clinmicnews.2015.10.003openalex-snapshot
Rapid Molecular Screening for Gram-Negative Antimicrobial-Resistance Genes with Commercially Available Methods
inferred← citeshttps://doi.org/10.1016/j.clinmicnews.2016.04.003openalex-snapshot
Polymyxin Susceptibility Testing: a Cold Case Reopened
inferred← citeshttps://doi.org/10.1016/j.clinthera.2019.04.038openalex-snapshot
A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2017.04.001openalex-snapshot
Evaluation of a real-time PCR assay for rectal screening of OXA-48-producing Enterobacteriaceae in a general intensive care unit of an endemic hospital
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2017.04.004openalex-snapshot
Transfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Enterobacter cloacae in a patient receiving meropenem therapy
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2017.04.015openalex-snapshot
Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2025.117077openalex-snapshot
Molecular analysis and ceftazidime–avibactam susceptibilities of carbapenem-resistant Klebsiella pneumoniae: Seven year experience from blood cultures of liver transplant recipients in a university hospital
inferred← citeshttps://doi.org/10.1016/j.drup.2016.09.002openalex-snapshot
The rapid spread of carbapenem-resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1016/j.fitote.2019.104273openalex-snapshot
Vochysiamides A and B: Two new bioactive carboxamides produced by the new species Diaporthe vochysiae
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e20561openalex-snapshot
The burden of hospital acquired infections and antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2016.10.025openalex-snapshot
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2017.08.005openalex-snapshot
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2018.07.004openalex-snapshot
Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2018.09.008openalex-snapshot
Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2020.106250openalex-snapshot
Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2021.106439openalex-snapshot
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2023.106933openalex-snapshot
Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2024.107418openalex-snapshot
Comparing ceftazidime/avibactam and polymyxin B for treating carbapenem-resistant organisms infections: A propensity score-matched retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.ijid.2016.06.017openalex-snapshot
Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation
inferred← citeshttps://doi.org/10.1016/j.ijid.2018.04.3693openalex-snapshot
The epidemiology of Gram negative bacteraemia at Tygerberg Hospital
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.05.079openalex-snapshot
Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
inferred← citeshttps://doi.org/10.1016/j.infpip.2020.100100openalex-snapshot
Carbapenemase screening in an Irish tertiary referral hospital: Best practice, or can we do better?
inferred← citeshttps://doi.org/10.1016/j.jgar.2018.05.018openalex-snapshot
Antimicrobial susceptibility of ertapenem-non-susceptible Enterobacteriaceae in South India
inferred← citeshttps://doi.org/10.1016/j.jgar.2019.05.028openalex-snapshot
New Delhi Metallo-β-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India
inferred← citeshttps://doi.org/10.1016/j.jgar.2019.07.031openalex-snapshot
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses
inferred← citeshttps://doi.org/10.1016/j.jgar.2020.09.022openalex-snapshot
In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1016/j.jgar.2021.07.014openalex-snapshot
In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014–2018
inferred← citeshttps://doi.org/10.1016/j.jgar.2024.10.263openalex-snapshot
Monte Carlo simulation for dosage optimization of the best available therapy for bloodstream infections secondary to carbapenemase-producing Klebsiella pneumoniae in critically ill patients
inferred← citeshttps://doi.org/10.1016/j.jiac.2019.12.004openalex-snapshot
In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE
inferred← citeshttps://doi.org/10.1016/j.jiac.2020.11.004openalex-snapshot
In vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand
inferred← citeshttps://doi.org/10.1016/j.jinf.2017.11.001openalex-snapshot
The impact of initial antibiotic treatment failure: Real-world insights in patients with complicated urinary tract infection
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2023.112425openalex-snapshot
Ruthenium(II) polypyridyl complexes as emerging photosensitisers for antibacterial photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.jiph.2017.07.020openalex-snapshot
Clinical and microbiological characteristics of Pantoea agglomerans infection in children
inferred← citeshttps://doi.org/10.1016/j.jiph.2018.04.013openalex-snapshot
Experience with ceftazidime–avibactam treatment in a tertiary care center in Saudi Arabia
inferred← citeshttps://doi.org/10.1016/j.jiph.2018.08.002openalex-snapshot
Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital
inferred← citeshttps://doi.org/10.1016/j.jiph.2020.04.010openalex-snapshot
Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of blaKPC harboring Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1016/j.jiph.2021.07.007openalex-snapshot
Antimicrobial resistance trends of non-fermenter Gram negative bacteria in Saudi Arabia: A six-year national study
inferred← citeshttps://doi.org/10.1016/j.jmii.2018.11.004openalex-snapshot
Recommendations and guidelines for the treatment of pneumonia in Taiwan
inferred← citeshttps://doi.org/10.1016/j.kjs.2025.100380openalex-snapshot
Potential effectiveness of Morchella conica and Morchella esculenta extracts against carbapenem resistant Acinetobacter baumannii
inferred← citeshttps://doi.org/10.1016/j.medmal.2019.12.011openalex-snapshot
Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome
inferred← citeshttps://doi.org/10.1016/j.micpath.2020.104120openalex-snapshot
Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem resistant Escherichia coli and Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1016/j.microc.2025.116417openalex-snapshot
Machine learning-enhanced SERS detection of carbapenem-resistant enterobacteriaceae using PEI-magnetic enrichment and Au@Ag core-shell nanoprobe
inferred← citeshttps://doi.org/10.1016/j.mimet.2018.09.001openalex-snapshot
Detection of carbapenem-resistant Enterobacteriaceae by chromogenic screening media
inferred← citeshttps://doi.org/10.1016/j.mjafi.2021.03.026openalex-snapshot
Rapid detection of carbapenem resistance among gram-negative organisms directly from positive blood culture bottles
inferred← citeshttps://doi.org/10.1016/j.nmni.2021.100860openalex-snapshot
Multicentre study of the main carbapenem resistance mechanisms in important members of the Enterobacteriaceae family in Iran
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2019.05.315openalex-snapshot
Antibiotic microbial resistance (AMR) removal efficiencies by conventional and advanced wastewater treatment processes: A review
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2019.06.533openalex-snapshot
Tracking the environmental dissemination of carbapenem-resistant Klebsiella pneumoniae using whole genome sequencing
inferred← citeshttps://doi.org/10.1016/j.transproceed.2016.05.005openalex-snapshot
Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant
inferred← citeshttps://doi.org/10.1016/j.watres.2020.115880openalex-snapshot
The role of the natural aquatic environment in the dissemination of extended spectrum beta-lactamase and carbapenemase encoding genes: A scoping review
inferred← citeshttps://doi.org/10.1017/s0950268822001030openalex-snapshot
Carbapenem-resistant Escherichia coli from shrimp and salmon available for purchase by consumers in Canada: a risk profile using the Codex framework
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00728openalex-snapshot
Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases
inferred← citeshttps://doi.org/10.1021/acsinfecdis.9b00318openalex-snapshot
Rapid Detection of Carbapenemase-Producing Enterobacteriacae Based on Surface-Enhanced Raman Spectroscopy with Gold Nanostars
inferred← citeshttps://doi.org/10.1038/s41429-017-0024-9openalex-snapshot
In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae
inferred← citeshttps://doi.org/10.1038/s41467-019-14139-5openalex-snapshot
Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei
inferred← citeshttps://doi.org/10.1038/s41587-019-0191-2openalex-snapshot
Hybrid metagenomic assembly enables high-resolution analysis of resistance determinants and mobile elements in human microbiomes
inferred← citeshttps://doi.org/10.1038/s41598-019-41489-3openalex-snapshot
Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli
inferred← citeshttps://doi.org/10.1038/s41598-020-71212-6openalex-snapshot
Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015
inferred← citeshttps://doi.org/10.1038/s41598-022-16275-3openalex-snapshot
Multiplexed paper-based assay for personalized antimicrobial susceptibility profiling of Carbapenem-resistant Enterobacterales performed in a rechargeable coffee mug
inferred← citeshttps://doi.org/10.1038/s41598-026-41530-2openalex-snapshot
Multiplex real-time PCR with high-resolution melting analysis for rapid identification of carbapenem and colistin resistance genes in clinical Enterobacterales isolates
inferred← citeshttps://doi.org/10.1038/s44259-025-00100-8openalex-snapshot
Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1055/s-0038-1677535openalex-snapshot
Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance
inferred← citeshttps://doi.org/10.1055/s-0039-1696662openalex-snapshot
Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and Treatment
inferred← citeshttps://doi.org/10.1080/07391102.2019.1581087openalex-snapshot
In vitro and in silico investigation of caprylic acid effect on multi drug resistant (MDR) Klebsiella pneumoniae biofilm
inferred← citeshttps://doi.org/10.1080/07391102.2019.1663262openalex-snapshot
Design of dipicolinic acid derivatives as New Delhi metallo-β-lactamase-1 inhibitors using a combined computational approach
inferred← citeshttps://doi.org/10.1080/14656566.2017.1341491openalex-snapshot
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections
inferred← citeshttps://doi.org/10.1080/14656566.2018.1538354openalex-snapshot
The antibiotic arms race: current and emerging therapy forKlebsiella pneumoniaecarbapenemase (KPC) - producing bacteria
inferred← citeshttps://doi.org/10.1080/14737167.2021.1964960openalex-snapshot
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia
inferred← citeshttps://doi.org/10.1080/14787210.2018.1522249openalex-snapshot
Multidrug-resistant Klebsiella pneumoniae : challenges for treatment, prevention and infection control
inferred← citeshttps://doi.org/10.1080/14787210.2019.1647103openalex-snapshot
Indian consensus on the management of CRE infection in critically ill patients (ICONIC) — India
inferred← citeshttps://doi.org/10.1080/14787210.2021.1902304openalex-snapshot
Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation
inferred← citeshttps://doi.org/10.1080/14787210.2022.2013806openalex-snapshot
Strengths and caveats of identifying resistance genes from whole genome sequencing data
inferred← citeshttps://doi.org/10.1080/14787210.2026.2730311openalex-snapshot
Advances in combination therapies for serious infections due to multidrug-resistant gram-negative bacilli
inferred← citeshttps://doi.org/10.1080/21505594.2016.1156821openalex-snapshot
Bloodstream infections in neutropenic cancer patients: A practical update
inferred← citeshttps://doi.org/10.1080/21505594.2016.1185577openalex-snapshot
Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1080/21505594.2016.1207834openalex-snapshot
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1080/21505594.2016.1213472openalex-snapshot
Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies
inferred← citeshttps://doi.org/10.1080/22221751.2026.2691352openalex-snapshot
Dissemination of bla KPC-3 -harbouring Klebsiella pneumoniae across ST48 and ST628 in multiple healthcare facilities in the Republic of Korea
inferred← citeshttps://doi.org/10.1080/23120053.2018.1509184openalex-snapshot
Epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) and comparison of the phenotypic versus genotypic screening tests for the detection of carbapenemases at a tertiary level, academic hospital in Johannesburg, South Africa
inferred← citeshttps://doi.org/10.1080/23744235.2018.1527470openalex-snapshot
Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections
inferred← citeshttps://doi.org/10.1089/adt.2016.701openalex-snapshot
Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1089/mdr.2017.0058openalex-snapshot
Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 ( bla NDM-1 ) in Bandar Abbas, South of Iran
inferred← citeshttps://doi.org/10.1089/mdr.2017.0400openalex-snapshot
Genomic Characterization of Nonclonal mcr-1- Positive Multidrug-Resistant Klebsiella pneumoniae from Clinical Samples in Thailand
inferred← citeshttps://doi.org/10.1089/mdr.2018.0006openalex-snapshot
Endemicity of the High-Risk Clone Klebsiella pneumoniae ST340 Coproducing QnrB, CTX-M-15, and KPC-2 in a Brazilian Hospital
inferred← citeshttps://doi.org/10.1089/mdr.2018.0234openalex-snapshot
Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1089/mdr.2019.0440openalex-snapshot
Prevalence and Mechanisms of Carbapenem Resistance in Klebsiella pneumoniae and Escherichia coli : A Systematic Review and Meta-Analysis of Cross-Sectional Studies from Iran
inferred← citeshttps://doi.org/10.1089/mdr.2019.0498openalex-snapshot
Investigation of the In Vitro Effectiveness of Aztreonam/Avibactam, Colistin/Apramycin, and Meropenem/Apramycin Combinations Against Carbapenemase-Producing, Extensively Drug-Resistant Klebsiella pneumoniae Strains
inferred← citeshttps://doi.org/10.1089/mdr.2022.0112openalex-snapshot
Molecular Screening of Clinical Multidrug-Resistant Gram-Negative Bacteria Shows Endemicity of Carbapenemases, Coexistence of Multiple Carbapenemases, and Rarity of mcr in South Africa
inferred← citeshttps://doi.org/10.1089/mdr.2024.0151openalex-snapshot
Risk Factors for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units: A Meta-Analysis
inferred← citeshttps://doi.org/10.1093/bfgp/elab038openalex-snapshot
Potential therapeutic targets of Klebsiella pneumoniae: a multi-omics review perspective
inferred← citeshttps://doi.org/10.1093/cid/ciaa1464openalex-snapshot
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000–2017
inferred← citeshttps://doi.org/10.1093/cid/ciy576openalex-snapshot
Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations
inferred← citeshttps://doi.org/10.1093/cid/ciz830openalex-snapshot
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
inferred← citeshttps://doi.org/10.1093/femspd/ftaa063openalex-snapshot
Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains ofKlebsiella pneumoniae
inferred← citeshttps://doi.org/10.1093/femspd/ftz034openalex-snapshot
Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China
inferred← citeshttps://doi.org/10.1093/jac/dkaa388openalex-snapshot
Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010–20
inferred← citeshttps://doi.org/10.1093/jac/dkab043openalex-snapshot
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales
inferred← citeshttps://doi.org/10.1093/jac/dkad229openalex-snapshot
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians
inferred← citeshttps://doi.org/10.1093/jac/dkae174openalex-snapshot
The prevalence and mechanisms of heteroresistance to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1093/jac/dkx241openalex-snapshot
Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology
inferred← citeshttps://doi.org/10.1093/jac/dky168openalex-snapshot
Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1093/jacamr/dlaa060openalex-snapshot
In vitroactivity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
inferred← citeshttps://doi.org/10.1093/jacamr/dlab081openalex-snapshot
In vitroactivity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France
inferred← citeshttps://doi.org/10.1093/jacamr/dlab102openalex-snapshot
Erratum to: In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France
inferred← citeshttps://doi.org/10.1093/jacamr/dlac106openalex-snapshot
Comparative effectiveness of antibiotic therapy for carbapenem-resistant Enterobacterales (CRE) bloodstream infections in hospitalized US veterans
inferred← citeshttps://doi.org/10.1093/jacamr/dlad113openalex-snapshot
Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1093/jacamr/dlae089openalex-snapshot
Evaluation of screening algorithms to detect rectal colonization with carbapenemase-producing Enterobacterales in a resource-limited setting
inferred← citeshttps://doi.org/10.1093/jphsr/rmab015openalex-snapshot
Cost-effectiveness of ceftazidime/avibactam for infections due to carbapenem-resistant bacteria in Peru
inferred← citeshttps://doi.org/10.1093/med/9780198701590.003.0086openalex-snapshot
Healthcare-associated infections and emergence of antibiotic resistance
inferred← citeshttps://doi.org/10.1093/milmed/usz148openalex-snapshot
Comparison of Carbapenem-Resistant Microbial Pathogens in Combat and Non-combat Wounds of Military and Civilian Patients Seen at a Tertiary Military Hospital, Philippines (2013–2017)
inferred← citeshttps://doi.org/10.1093/ofid/ofy241openalex-snapshot
Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
inferred← citeshttps://doi.org/10.1097/01.nme.0000508539.12413.ebopenalex-snapshot
Five MDROs you need to know
inferred← citeshttps://doi.org/10.1097/inf.0000000000002381openalex-snapshot
Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms
inferred← citeshttps://doi.org/10.1097/mjt.0000000000000683openalex-snapshot
Updates in Management of Complicated Urinary Tract Infections: A Focus on Multidrug-Resistant Organisms
inferred← citeshttps://doi.org/10.1097/mph.0000000000002142openalex-snapshot
Is Carbapenem-resistant Klebsiella pneumoniae Infection in Pediatric Bone Marrow Transplantation Recipients Inevitably Fatal?
inferred← citeshttps://doi.org/10.1097/mrm.0000000000000182openalex-snapshot
Systematic review of antibacterial activity of eravacycline: a novel fluorocycline against clinically obtained Gram-negative bacteria
inferred← citeshttps://doi.org/10.1097/qco.0000000000000313openalex-snapshot
Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?
inferred← citeshttps://doi.org/10.1097/qco.0000000000000314openalex-snapshot
The management of multidrug-resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1099/jmm.0.000508openalex-snapshot
The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India
inferred← citeshttps://doi.org/10.1099/jmm.0.000973openalex-snapshot
The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria
inferred← citeshttps://doi.org/10.1099/jmm.0.001381openalex-snapshot
mCIM test as a reliable assay for the detection of CRE in the Gulf region
inferred← citeshttps://doi.org/10.1099/jmm.0.001960openalex-snapshot
Phenotype and genotype of carbapenem-resistant hypervirulent Klebsiella pneumoniae in a teaching hospital in Shanghai, China
inferred← citeshttps://doi.org/10.1099/jmm.0.002029openalex-snapshot
Improved diagnostic stewardship in carbapenem-resistant Enterobacterales gene detection helps in early initiation of targeted therapy
inferred← citeshttps://doi.org/10.1099/mgen.0.000789openalex-snapshot
Piperacillin/tazobactam-resistant, cephalosporin-susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types
inferred← citeshttps://doi.org/10.1101/2020.09.18.302992openalex-snapshot
Piperacillin/tazobactam resistant, cephalosporin susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types
inferred← citeshttps://doi.org/10.1101/2023.09.10.23295341openalex-snapshot
Detection of carbapenem resistance genes in Campylobacter coli and Campylobacter jejuni isolated from chickens, and diarrheic children aged less than five years in Kampala city, Uganda
inferred← citeshttps://doi.org/10.1101/399170openalex-snapshot
Simulation of enteric colonisation by and screening for Carbapenemase Producing Enterobacteriaceae using an in-vitro human gut model
inferred← citeshttps://doi.org/10.1101/456905openalex-snapshot
Nanopore sequencing enables high-resolution analysis of resistance determinants and mobile elements in the human gut microbiome
inferred← citeshttps://doi.org/10.1101/495986openalex-snapshot
Different impacts of naturally occurring variants of the globally disseminated carbapenemase-encoding plasmid pKpQIL on the biology of host strains
inferred← citeshttps://doi.org/10.1101/534958openalex-snapshot
Inoculum size effects in bla IMP-6 and plasmid-mediated quinolone resistance gene-positive Enterobacteriaceae in Japan
inferred← citeshttps://doi.org/10.1111/1348-0421.70096openalex-snapshot
Development and Application of a Rapid 23S rRNA‐Targeted Reverse Transcription Quantitative PCR System for the Detection and Quantification of Enterobacterales
inferred← citeshttps://doi.org/10.1111/bcp.14692openalex-snapshot
Population pharmacokinetics and exposure‐response analysis of tigecycline in patients with hospital‐acquired pneumonia
inferred← citeshttps://doi.org/10.1111/ctr.13594openalex-snapshot
Multidrug‐resistant Gram‐negative bacterial infections in solid organ transplant recipients—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
inferred← citeshttps://doi.org/10.1111/iju.13787openalex-snapshot
Occurrence and characterization of carbapenem‐resistant Gram‐negative bacilli: A collaborative study of antibiotic‐resistant bacteria between Indonesia and Japan
inferred← citeshttps://doi.org/10.1111/lam.13368openalex-snapshot
Occurrence of the genes encoding carbapenemases, ESBLs and class 1 integron‐integrase among fermenting and non‐fermenting bacteria from retail goat meat
inferred← citeshttps://doi.org/10.1111/tid.12757openalex-snapshot
Impact of carbapenem‐resistant K lebsiella pneumoniae ( CR ‐ KP ) infections in kidney transplantation
inferred← citeshttps://doi.org/10.1111/tid.12837openalex-snapshot
Carbapenem‐resistant K lebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime‐avibactam
inferred← citeshttps://doi.org/10.1111/tid.13474openalex-snapshot
Treatment of multidrug‐resistant gram‐negative bacilli after solid organ transplant: Outcomes and complications
inferred← citeshttps://doi.org/10.11124/jbisrir-d-18-00019openalex-snapshot
Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence
inferred← citeshttps://doi.org/10.1117/12.2269911openalex-snapshot
A gold nanostar-based SERS platform for point-of-care diagnostics of carbapenemase-producing enterobacteriacae
inferred← citeshttps://doi.org/10.1126/science.aan0003openalex-snapshot
A modular and enantioselective synthesis of the pleuromutilin antibiotics
inferred← citeshttps://doi.org/10.1128/aac.00107-16openalex-snapshot
Global Dissemination of bla KPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
inferred← citeshttps://doi.org/10.1128/aac.00433-18openalex-snapshot
The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination
inferred← citeshttps://doi.org/10.1128/aac.00499-20openalex-snapshot
Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018
inferred← citeshttps://doi.org/10.1128/aac.00519-19openalex-snapshot
Identification of a Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae Isolate in the United States
inferred← citeshttps://doi.org/10.1128/aac.00591-22openalex-snapshot
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
inferred← citeshttps://doi.org/10.1128/aac.00675-21openalex-snapshot
Nationwide Surveillance and Molecular Characterization of Critically Drug-Resistant Gram-Negative Bacteria: Results of the Research University Network Thailand Study
inferred← citeshttps://doi.org/10.1128/aac.00897-19openalex-snapshot
Cost-Effectiveness of Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia and Pneumonia
inferred← citeshttps://doi.org/10.1128/aac.00906-25openalex-snapshot
Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant Enterobacter cloacae
inferred← citeshttps://doi.org/10.1128/aac.01074-18openalex-snapshot
In Vivo Efficacy of Plazomicin Alone or in Combination with Meropenem or Tigecycline against Enterobacteriaceae Isolates Exhibiting Various Resistance Mechanisms in an Immunocompetent Murine Septicemia Model
inferred← citeshttps://doi.org/10.1128/aac.01128-18openalex-snapshot
A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function
inferred← citeshttps://doi.org/10.1128/aac.01345-16openalex-snapshot
Molecular Epidemiology and Genome Dynamics of New Delhi Metallo-β-Lactamase-Producing Extraintestinal Pathogenic Escherichia coli Strains from India
inferred← citeshttps://doi.org/10.1128/aac.01511-18openalex-snapshot
Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant Enterobacteriaceae Bacteremia
inferred← citeshttps://doi.org/10.1128/aac.01815-17openalex-snapshot
Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1128/aac.01963-19openalex-snapshot
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1128/aac.02048-18openalex-snapshot
Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae
inferred← citeshttps://doi.org/10.1128/aac.02097-16openalex-snapshot
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
inferred← citeshttps://doi.org/10.1128/aac.02271-20openalex-snapshot
Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacterales in Animal Infection Models: a Current State of Affairs
inferred← citeshttps://doi.org/10.1128/aac.02313-19openalex-snapshot
Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
inferred← citeshttps://doi.org/10.1128/aac.02329-18openalex-snapshot
Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies
inferred← citeshttps://doi.org/10.1128/aac.02382-18openalex-snapshot
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model
inferred← citeshttps://doi.org/10.1128/aac.02638-15openalex-snapshot
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1128/aac.03118-15openalex-snapshot
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase
showing the first 200 of 430 · page through all 430
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.